IgM antibodies play important roles in protection and in adaptive immune responses. Normally, IgM is secreted as pentamers but other forms, including monomers, are sometimes produced. These are prevalent in various diseases, including chronic infections and certain autoimmune diseases. The overall goals of the proposed experiments are to help understand the role that IgM plays in immunity to pathogens and to determine if IgM monomers are beneficial or deleterious to the host. To accomplish this, 1) we will determine the effect of monomeric IgM on primary and secondary immune responses to specific antigens using a transgenic mouse model in which a mutant secretory mu chain (musC575A), which does not polymerize normally, has been expressed. We will determine the consequences, either positive or negative, of the expression of monomeric IgM in the presence and absence of pentameric IgM. 2) We will produce mice in which the endogenous secretory mu gene contains a targeted mutation such that the secretory IgM produced is non-polymeric. These mice will be evaluated for their ability to generate primary and secondary immune responses, and to clear pathogens. The repertoire of natural antibodies with specificities for particular antigens on pathogens will be compared with that of normal and secretory IgM deficient mice. 3) We will determine if the presence of high concentrations of monomeric IgM (also called low molecular weight, LMW IgM) leads to systemic autoimmune disease, either alone or in combination with wildtype IgM or antibodies of other isotypes. We will determine the role of T cells in this process. 4) We will determine if LMW IgM is an accelerator or autoimmune disease in susceptible mice. We will also determine if the presence of genes that predispose toward autoimmunity leads to increased production of LMW IgM. Finally, 5) we will determine if the redox state of B cells is altered in mice undergoing chronic infections, and/or in B cells producing LMW IgM compared with that of normal B cells. We will test the hypothesis that these changes lead to alterations in the quality control standards that regulate IgM assembly and secretion, resulting in the increased production of monomeric IgM. Together, the results of these experiments will provide novel insights into the role of IgM in natural immunity and in disease, and will also shed new light on the pathogenic effects of monomeric IgM.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI031209-12
Application #
6627986
Study Section
Special Emphasis Panel (ZRG1-EI (02))
Program Officer
Mallia, Conrad M
Project Start
1991-03-01
Project End
2005-01-31
Budget Start
2003-02-01
Budget End
2004-01-31
Support Year
12
Fiscal Year
2003
Total Cost
$317,566
Indirect Cost
Name
Boston University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Doerre, Stefan; Mesires, Kristin Perkins; Daley, Kylle M et al. (2005) Reductions in I kappa B epsilon and changes in NF-kappa B activity during B lymphocyte differentiation. J Immunol 174:983-91
Corley, R B; Morehouse, E M; Ferguson, A R (2005) IgM accelerates affinity maturation. Scand J Immunol 62 Suppl 1:55-61
Ferguson, Andrew R; Corley, Ronald B (2005) Accumulation of marginal zone B cells and accelerated loss of follicular dendritic cells in NF-kappaB p50-deficient mice. BMC Immunol 6:8
Ferguson, Andrew R; Youd, Michele E; Corley, Ronald B (2004) Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. Int Immunol 16:1411-22
Flemming, Jennifer A; Perkins, Kristin H; Luus, Lia et al. (2004) Disruption of membrane cholesterol stimulates MyD88-dependent NF-kappaB activation in immature B cells. Cell Immunol 229:68-77
Youd, Michele E; Ferguson, Andrew R; Corley, Ronald B (2002) Synergistic roles of IgM and complement in antigen trapping and follicular localization. Eur J Immunol 32:2328-37
Reddy, P S; Corley, R B (1999) The contribution of ER quality control to the biologic functions of secretory IgM. Immunol Today 20:582-8
Doerre, S; Corley, R B (1999) Constitutive nuclear translocation of NF-kappa B in B cells in the absence of I kappa B degradation. J Immunol 163:269-77
Reddy, P S; Corley, R B (1998) Assembly, sorting, and exit of oligomeric proteins from the endoplasmic reticulum. Bioessays 20:546-54
Hughey, C T; Brewer, J W; Colosia, A D et al. (1998) Production of IgM hexamers by normal and autoimmune B cells: implications for the physiologic role of hexameric IgM. J Immunol 161:4091-7

Showing the most recent 10 out of 19 publications